Developing Genetic Epidemiological Models to Predict Risk for Nasopharyngeal Carcinoma in High-Risk Population of China

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ruan, Hong Lian ^a,b   Qin, Hai De ^c   Shugart, Yin Yao ^c   Bei, Jin Xin ^a   Luo, Fu Tian ^b   Zeng, Yi Xin ^a   Jia, Wei Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CHINA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; FOOD; FOOD INTAKE; FOOD PRESERVATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PROCESS DEVELOPMENT; RISK ASSESSMENT; SALTED FISH; SMOKING; VEGETABLE;

AGED; CASE-CONTROL STUDIES; CHINA; COMPUTER SIMULATION; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; MODELS, GENETIC; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84874053030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056128     Document Type: Article

References (40)

1. (2002) Cancer incidence in five continents. Volume VIII. IARC Sci Publ: 1-781.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Jia WH, Huang QH, Liao J, Ye W, Shugart YY, et al. (2006) Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer 6: 178.
4. Zeng YX, Jia WH, (2002) Familial nasopharyngeal carcinoma. Semin Cancer Biol 12: 443-450.
5. Chang ET, Adami HO, (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1765-1777.
6. Gallicchio L, Matanoski G, Tao XG, Chen L, Lam TK, et al. (2006) Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer 119: 1125-1135.
7. Jia WH, Qin HD, (2012) Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review. Semin Cancer Biol 22: 117-126.
8. Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX, et al. (2010) Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China. BMC Cancer 10: 446.
9. Xu FH, Xiong D, Xu YF, Cao SM, Xue WQ, et al. (2012) An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and epstein-barr virus activation. J Natl Cancer Inst 104: 1396-1410.
10. Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB, (1976) Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 295: 1101-1106.
11. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, et al. (1990) Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346: 470-471.
12. Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, et al. (2005) Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer 115: 742-746.
13. Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 85: 194-203.
14. Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42: 599-603.
15. Paynter NP, Chasman DI, Pare G, Buring JE, Cook NR, et al. (2010) Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 303: 631-637.
16. Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, et al. (2010) Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst 102: 972-981.
17. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, et al. (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362: 986-993.
18. Johansson M, Holmstrom B, Hinchliffe SR, Bergh A, Stenman UH, et al. (2012) Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study. Int J Cancer 130: 129-137.
19. Hsu FC, Sun J, Zhu Y, Kim ST, Jin T, et al. (2010) Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history. Cancer Epidemiol Biomarkers Prev 19: 1083-1088.
20. Hsu FC, Lindstrom S, Sun J, Wiklund F, Chen SH, et al. (2008) A multigenic approach to evaluating prostate cancer risk in a systematic replication study. Cancer Genet Cytogenet 183: 94-98.
21. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, et al. (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340: b4838.
22. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, (2011) Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ 342: d631.
23. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, et al. (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116.
24. Cao SM, Liu Z, Jia WH, Huang QH, Liu Q, et al. (2011) Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One 6: e19100.
25. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
26. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172; discussion 207-112.
27. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1886.
28. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, et al. (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 95: 470-478.
29. Austin PC, Tu JV, (2004) Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 57: 1138-1146.
30. Facio FM, Feero WG, Linn A, Oden N, Manickam K, et al. (2010) Validation of My Family Health Portrait for six common heritable conditions. Genet Med 12: 370-375.
31. Guttmacher AE, Collins FS, Carmona RH, (2004) The family history-more important than ever. N Engl J Med 351: 2333-2336.
32. Ng CC, Yew PY, Puah SM, Krishnan G, Yap LF, et al. (2009) A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 54: 392-397.
33. Kraft P, Hunter DJ, (2009) Genetic risk prediction-are we there yet? N Engl J Med 360: 1701-1703.
34. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358: 1240-1249.
35. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE, (2009) Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 5: e1000337.
36. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359: 2208-2219.
37. Vassy JL, Meigs JB, (2012) Is Genetic testing useful to predict type 2 diabetes? Best Pract Res Clin Endocrinol Metab 26: 189-201.
38. Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, et al. (2009) Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res 15: 1105-1111.
39. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, et al. (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358: 910-919.
40. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, et al. (2006) Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 8: 395-400.